137310 — SD Biosensor Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual income statement for SD Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	72,962	1,686,163	2,929,961	2,932,001	655,677
Cost of Revenue
Gross Profit	20,810	858,162	1,593,923	1,392,995	126,002
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	71,443	947,899	1,544,511	1,794,011	1,003,630
Operating Profit	1,520	738,264	1,385,450	1,137,990	-347,953
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,202	717,237	1,464,509	1,242,088	-438,614
Provision for Income Taxes
Net Income After Taxes	3,131	621,614	1,088,124	908,789	-467,904
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,153	615,636	1,088,471	911,362	-467,712
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,153	615,636	1,088,471	911,362	-467,712
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	30.9	5,966	11,189	9,072	-3,627
Dividends per Share